The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHill & Smith Regulatory News (HILS)

Share Price Information for Hill & Smith (HILS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,902.00
Bid: 1,900.00
Ask: 1,906.00
Change: 12.00 (0.63%)
Spread: 6.00 (0.316%)
Open: 1,860.00
High: 1,932.00
Low: 1,860.00
Prev. Close: 1,890.00
HILS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

1 Oct 2020 13:14

RNS Number : 8380A
Hill & Smith Hldgs PLC
01 October 2020
 

Hill & Smith Holdings PLC ('Hill & Smith' or 'the Company')Director and PDMR Shareholdings

1 October 2020

Hill & Smith 2014 Long-Term Incentive Plan

LTIP Award - 25 September 2020

On 24 September 2020 the Remuneration Committee of the Company approved the grant of awards, to be made on 25 September 2020, in the form of nil-cost options over ordinary shares in the Company in accordance with the provisions of the Hill & Smith Holdings 2014 Long Term Incentive Plan (the "LTIP"). 

Mr P Simmons has been granted a nil-cost option over 66,819 ordinary shares and Mrs H K Nichols has been granted a nil-cost option over 35,335 ordinary shares.

The awards were based on a share price of 1201p, being the average of the mid-market prices for the three trading days prior to the grant date of 25 September 2020. 

Both Mr Simmons and Mrs Nichols were also granted an award in the form of a tax qualifying option, in accordance with the provisions of the Hill & Smith Holdings 2014 Executive Share Option Scheme (the "ESOS"), over 2,497 ordinary shares with an exercise price of 1201p per ordinary share on terms which are similar to the awards under the LTIP (together the "Awards"). If the options under the ESOS are exercised at a gain, the LTIP awards will be reduced by the same value to ensure that the combined pre-tax value delivered to participants is not increased by the grant of the ESOS option.

Under the rules of the LTIP and the Company's Remuneration Policy, the vesting of the Awards is subject to the achievement of set performance conditions. In the Directors' Remuneration Report for the year ending 31 December 2019, the Company noted that it was reviewing the performance measures and targets and would confirm these when the awards were granted. As with previous years, the performance measures are based 50% upon the Company's underlying earnings per share and 50% upon its Total Shareholder Return ('TSR'). The relative TSR measure (including the comparator group) remains the same as previously. Having regard to the impact of the Covid-19 pandemic, the Remuneration Committee has concluded that it would be better to set the EPS targets as absolute rather than growth measures. The performance measures and targets are summarised below.

Vesting amount

Underlying Earnings per Share for the year ending 31 December 2022 (50% of the Awards)

TSR performance over the three years ending 31 December 2022 (50% of the Awards)**

0% vesting

Less than £0.80

Below median

Threshold: 20% vesting

£0.85

Median

100% vesting*

100p

Upper quartile

*Straight line vesting applies between threshold and maximum vesting

** compared to the FTSE 250 excluding investment trusts and financial services companies

The Awards will (subject to the achievement of the performance conditions) vest following the end of the performance period but may not ordinarily be exercised until the end of a further two year holding period.

 

Buy-out Award

On the same day the Remuneration Committee approved the grant to Mr P Simmons of two additional share awards in the form of nil-cost options over ordinary shares in the Company. These awards reflect two awards that Mr Simmons forfeited at his previous employer and were agreed as part of his recruitment package. The awards were determined by the Remuneration Committee having regard to the extent to which the performance conditions attached to the forfeited awards were assumed to be satisfied and the proportion of the performance periods for those awards which have elapsed. The awards and their vesting dates are set out below.

Buy-Out Award

Number of Shares

Vesting Date

Buy-Out Award 1

28,557

30 July 2021

Buy-Out Award 2

12,364

29 July 2022

 

As noted in the announcement of 2 April 2020, the full terms of Mr Simmons' remuneration package will be included in the Company's Directors' Remuneration Report for the year ending 31 December 2020.  

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Mr P Simmons

2.

Reason for the notification

(a)

Position/status

Chief Executive Officer Designate

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith Holdings PLC

(b)

LEI

 2138003A3ISGQZBOWI83

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

i. Grant of Nil-Cost Option as part of 2020 LTIP Award 

ii. Grant of ESOS Option as part of 2020 LTIP Award at an exercise price of 1201p per share

iii Grant of Buy-Out Award 1

iv Grant of Buy-Out Award 2

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

i. Nil

ii. Nil

iii Nil

iv Nil

i. 66,819

ii. 2,497

iii 28,557

iv 12,364

(e)

Aggregated information

 

- Aggregated volume

 110,237 shares

- Price

Nil Cost

(f)

Date of the transaction

25 September 2020

(g)

Place of the transaction

Outside a trading venue

 

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Mrs H K Nichols

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith Holdings PLC

(b)

LEI

 2138003A3ISGQZBOWI83

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

i. Grant of Nil-Cost Option as part of 2020 LTIP Award

 

ii. Grant of ESOS Option as part of 2020 LTIP Award at an exercise price of 1201p per share

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

i. Nil

ii. Nil

i. 35,335

ii. 2,497

(e)

Aggregated information

 

- Aggregated volume

 37,832 shares

- Price

Nil Cost

(f)

Date of the transaction

25 September 2020

(g)

Place of the transaction

Outside a trading venue

 

Enquiries:

 Alex Henderson

Company Secretary

Tel: +44 (0) 121 704 7430

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLFIFLLIII
Date   Source Headline
2nd Feb 20217:00 amRNSBoard Appointment
1st Feb 202111:22 amRNSTotal Voting Rights
27th Jan 20219:31 amRNSDirector Declaration
22nd Jan 20212:01 pmRNSBlock listing Interim Review
5th Jan 20214:13 pmRNSPreliminary Results Timetable
4th Jan 20215:43 pmRNSTotal Voting Rights
1st Dec 20203:25 pmRNSTotal Voting Rights
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:38 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSTrading Update
10th Nov 20207:00 amRNSTotal Voting Rights
2nd Nov 20201:47 pmRNSTotal Voting Rights
13th Oct 20203:21 pmRNSDirector/PDMR Shareholding
1st Oct 20201:14 pmRNSDirector/PDMR Shareholding
1st Oct 20201:10 pmRNSTotal Voting Rights - Replacement
1st Oct 202012:52 pmRNSTotal Assets Value
1st Sep 20208:43 amRNSTotal Voting Rights
24th Aug 202012:39 pmRNSDirector/PDMR Shareholding
17th Aug 202012:44 pmRNSDirector/PDMR Shareholding
10th Aug 20204:14 pmRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSHalf Year Results
3rd Aug 202011:52 amRNSTotal Voting Rights
22nd Jul 202010:12 amRNSBLOCK LISTING SIX MONTHLY RETURN
1st Jul 20202:09 pmRNSTotal Voting Rights
25th Jun 20209:41 amRNSDirector/PDMR Shareholding
24th Jun 20201:21 pmRNSResult of AGM
17th Jun 20207:00 amRNSTrading Update
1st Jun 20202:29 pmRNSTotal Voting Rights
27th May 20203:10 pmRNSNotice of Trading Update
26th May 20207:00 amRNSAnnual Report and Notice
4th May 20202:26 pmRNSTotal Voting Rights
30th Apr 202010:54 amRNSDisclosure of Rights Attached to Equity Shares
2nd Apr 20202:21 pmRNSDirector/PDMR Shareholding
2nd Apr 20201:11 pmRNSTotal Voting Rights
2nd Apr 20207:00 amRNSBoard Appointment
27th Mar 20207:00 amRNSCOVID-19 Update
4th Mar 20207:00 amRNSFinal Results
2nd Mar 202010:33 amRNSTotal Voting Rights
3rd Feb 202011:48 amRNSTotal Voting Rights
29th Jan 20207:00 amRNSChange of Auditor 2020
22nd Jan 202012:26 pmRNSBLOCK LISTING SIX MONTHLY RETURN
13th Jan 20203:42 pmRNSDirector/PDMR Shareholding
6th Jan 20201:35 pmRNSTotal Voting Rights
10th Dec 20197:00 amRNSCapital Markets Day
3rd Dec 201910:28 amRNSTotal Voting Rights
2nd Dec 20197:00 amRNSBoard Appointments
21st Nov 20197:00 amRNSTrading Statement
6th Nov 20192:41 pmRNSDirector/PDMR Shareholding
1st Nov 20192:32 pmRNSTotal Voting Rights
2nd Oct 20193:14 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.